Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Citrus flavonoid F-1 protects rats from beta--amyloid-induced learning impairment

April 1, 2005

Dosing under way in phase I study of CR-665 for postoperative pain

April 1, 2005

Zofran approved for children aged one month and older

March 31, 2005

Eisai seeks European approval of Inovelon for Lennox-Gastaut Syndrome

March 31, 2005

KMI-429 reduces beta-amyloid production in mice

March 31, 2005

New patents cover treatments for Alzheimer's disease

March 31, 2005

Gene therapy claimed for the treatment of pain

March 31, 2005

NS-2359 advanced into phase II

March 31, 2005

Complement inhibitors for neurodegenerative, autoimmune disorders disclosed in recent patents

March 30, 2005

Rasagiline improves fluctuations in levodopa-treated Parkinson's disease patients

March 30, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...